Consultant CPD, November 23rd 2016

Slides:



Advertisements
Similar presentations
Unstable angina and NSTEMI
Advertisements

Single Unit Transfusion for Red Blood Cell Transfusion
Single Unit Blood Transfusion Guideline for Laboratory Staff Based on the Patient Blood Management Guidelines Be SINGLE minded.
Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
Pablo M. Bedano M.D. Community Regional Cancer Care.
HEFT EMCAST UPPER GI BLEEDS; WHAT’S YOUR THRESHOLD?
Dr Craig French. Anaemia is bad for you. BUT Is correction of anaemia with Red Blood Cell transfusion good for you?
ESAs and Outcomes in CKD Patients Philip Lui PharmD The 13th Annual Contemporary Therapeutic Issues in Cardiovascular Disease May 8, 2010.
Spotlight Case Transfusion Overload. 2 Source and Credits This presentation is based on the November 2012 AHRQ WebM&M Spotlight Case –See the full article.
THE TRISS TRIAL Holst, L et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock. New England Journal of Medicine October 9, 2014.
Prescribing Information is available at the end of this presentation NHS Surrey Lipid Guidelines Dr Adam Jacques Ashford & St.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Nebulized Hypertonic Saline for Bronchiolitis Florin TA, Shaw KN, Kittick M, Yakscoe.
NKF-KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease UPDATE OF HEMOGLOBIN TARGET Am.J.Kidney.Dis.
Single Unit Transfusion Guideline for Red Blood Cell Transfusion
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
BLOOD TRANSFUSIONS Dr. Tamara Wagenheim.
Red Cell Transfusion in Critical Care Patients Alan Tinmouth, MD MSc University of Ottawa Centre for Transfusion Research, Ottawa Health Research Institute.
Reduction of RBC transfusions based on standardized hemoglobin evaluation for adult non-ICU patients Kathryn Curcione RN, BSN, ONC, NE-BC, Molly Rankin,
Monthly Journal article review: Vimmi Kang PGY 2
RESULTS FROM THE 2007 SHOT REPORT. SHOT report 2007 (561 cases)
Advances in Transfusion and Blood Conservation Arman Kilic, MD Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
Anemia in the Hospitalized Elderly Hospitalist Best Practice J Rush Pierce Jr, MD, MPH February 29, 2012.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
RBC transfusions in critically ill patients TMR Journal Club March 1, 2007 Maggie Constantine.
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
A pilot randomized controlled trial Registry #: NCT
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Support for implementing NICE guidance: Unstable angina and NSTEMI Unstable angina and NSTEMI, CG94, rd Edition March 2014.
R1. 최태웅 / Pf. 김정욱. INTRODUCTION Acute upper gastrointestinal bleeding (AUGIB) : incidence of 50–150 cases/100,000 : outcomes → by preexisting comorbidity,
Geriatrics Journal Club Yee Chuan Ang, MD Geriatric Medicine Fellow PGY-4 Boston University School of Medicine.
Josephine Mak Waikato Cardiothoracic Unit Journal Club
Management of Hypertension according to JNC 7
An AKI project for critically ill cancer patients
Transfusion thresholds for cancer patients
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
Surgical ICU, Heart Institute University of São Paulo
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
The British Heart Foundation older patients with non-ST SEgmeNt elevatIOn myocaRdial infarction Randomized Interventional TreAtment Trial The BHF SENIOR-RITA.
Copenhagen University Hospital Rigshospitalet, Denmark
Results of a kidney-protection strategy during open thoracoabdominal aortic surgery according to RIFLE criteria.
HOPE: Heart Outcomes Prevention Evaluation study
Clinical need for determination of vulnerable plaques
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
AUDIT OF RED BLOOD CELL TRANSFUSION PRACTICE IN THE ITU SETTING
Κολπικη μαρμαρυγη σε ασθενεις με αποφρακτικη υπνικη απνοια
Blood Transfusion Evidence-Based Blood Therapeutics “7 is the NEW 10”
Avoiding Cardiovascular events through COMbination therapy in Patients LIving with Systolic Hypertension (ACCOMPLISH): Design Randomized, double-blind.
Systolic Blood Pressure Intervention Trial (SPRINT)
Dabigatran in myocardial injury after noncardiac surgery
Recurrent Angina: New Tools for an Old Problem
European Heart Association Journal 2007 April
NOACS: Emerging data in ACS/IHD
RBWH ICU JOURNAL CLUB NOVEMBER 2014.
PRBC Transfusions Medicine Floors Internal Medicine, PGY-3
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Monthly Journal article review: Vimmi Kang PGY 2
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Dabigatran in myocardial injury after noncardiac surgery
Deprescribing Calcium-Based Phosphorus Binders in Dialysis Patients
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
ARISE Trial Aggressive Reduction of Inflammation Stops Events
Dabigatran in myocardial injury after noncardiac surgery
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Dr Donal O’Donoghue National Clinical Director for Kidney Care
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Consultant CPD, November 23rd 2016 Blood Transfusion Consultant CPD, November 23rd 2016

Blood is good

Blood is good DO2 = CO x CaO2

Blood is bad Pull out Betty! You’ve hit an artery

Blood is bad Infections Transfusion reactions TRALI TACO Chemical effects due to storage Microcirculation Immunomodulation

Blood is bad Infections Transfusion reactions TRALI TACO Chemical effects due to storage Microcirculation Immunomodulation

Blood is bad

Happy medium?

Restrictive transfusion Happy medium? The policy of giving blood only when benefits are deemed to outweigh potential risks Restrictive transfusion

Restrictive vs liberal transfusion strategies

Restrictive vs liberal transfusion strategies

Restrictive vs liberal transfusion strategies The evidence Restrictive vs liberal transfusion strategies 7 key RCTs General / critical care population Cardiac patients [TBI and SAH]

The TRICC study

The TRICC study LIBERAL RESTRICTIVE OUTCOMES Hb 100 -120 Hb 70 -90 Death at 30 days & 60 days, organ failures

The TRICC study LIBERAL RESTRICTIVE (2.6 ± 4.1) P<0.01 Hb 107 ± 7 (5.6 ± 5.3) RESTRICTIVE (2.6 ± 4.1) Hb 85 ± 7 P<0.01

The TRICC study

The TRICC study

The TRICC study

The TRICC study

The TRICC study

The FOCUS study

The FOCUS study 2016 pts >50yrs IHD or risk factors Hb <100 ♯ hip

The FOCUS study

The FOCUS study LIBERAL RESTRICTIVE OUTCOMES Hb >100 Hb < 80 or signs & symptoms OUTCOMES Death at 60 days or inability to walk >10ft

The FOCUS study

The FOCUS study

The FOCUS study

The FOCUS (2)study

The FOCUS (2) study

The RELIEVE study >55yrs CCM

The RELIEVE study LIBERAL RESTRICTIVE OUTCOMES Hb>90 (91-110) Difference in mean Hb, mortality, adverse events, HRQoL

The RELIEVE study

The RELIEVE study No significant difference in mortality or any of the other outcome measures

Ischaemic Heart Disease

IHD pts Am Heart Journal 2011; 162:300

IHD pts Hospital-acquired anemia was defined as development of new anemia during hospitalization using age, gender, and race specific criteria Mild – less than normal - >110 Moderate – 90-110 Severe - <90

IHD pts

The MINT study

The MINT study STEMI Non STEMI Unstable angina Cardiac catheter Hb<100

The MINT study LIBERAL RESTRICTIVE OUTCOMES Hb >100 Symptomatic Death, MI, unscheduled revascularisation

The MINT study

The MINT study

The TRACS study

The TRACS study LIBERAL RESTRICTIVE OUTCOMES Ht >30 Ht >24 Death, severe morbidity (CVS, RS, Renal)

The TRACS study

The TRACS study

The TRACS study

Upper GI bleed pts

Upper GI bleed pts LIBERAL RESTRICTIVE OUTCOMES Hb 90 -110 Hb 70 -90 Death at 45 days, re-bleed, in hospital complications

Upper GI bleed pts No transfusion 51% vs 14%

Upper GI bleed pts

Upper GI bleed pts

The TRISS study

The TRISS study

The TRISS study LIBERAL RESTRICTIVE OUTCOMES Hb >90 Hb >70 Death at 90 days

The TRISS study

The TRISS study

The TRISS study

The TITRe2 study

The TITRe2 study LIBERAL RESTRICTIVE OUTCOMES Hb >90 Hb >75 10 - Sepsis, Ischaemic events within 3 months 20 - ICU stay, all cause mortality

The TITRe2 study RESULTS 10 outcome 35% vs 33% 20 outcome 4.2 vs 2.6% Protocol violations

TBI & SAH patients

TBI & SAH patients Transfusion Medicine 2016

TBI & SAH patients Very sparse evidence For TBI Hb 70 – 90 For SAH 80 - 100

TBI & SAH patients JAMA 2014

TBI & SAH patients

TBI & SAH patients

TBI & SAH patients

Cochrane review

Cochrane review 19 trials 6264 pts

Cochrane review Adverse events and other outcomes None of the outcomes evaluated, including mortality, cardiac morbidity, infections and length of hospital stay, appear to be adversely affected by the lower use of red cell transfusions.

Cochrane review In contrast, the evidence raises the possibility of harm associated with liberal transfusion. In-hospital mortality increased by 23% infections were increased by19% .

Cochrane review In patients who do not have acute coronary artery disease, blood transfusion can probably be withheld in the presence of haemoglobin levels as low as 70 to 80 as long as there is no notable bleeding.

NICE recommendations Red blood cells Thresholds and targets Use restrictive red blood cell transfusion thresholds for patients who need red blood cell transfusions and who do not: have major haemorrhage or have acute coronary syndrome or need regular blood transfusions for chronic anaemia. .

NICE recommendations Red blood cells Thresholds and targets When using a restrictive red blood cell transfusion threshold, consider a threshold of 70 g/litre and a haemoglobin concentration target of 70–90 g/litre after transfusion. Consider a red blood cell transfusion threshold of 80 g/litre and a haemoglobin concentration target of 80–100 g/litre after transfusion for patients with acute coronary syndrome.

Questions?